Why Attend
CAR-T therapy is set to revolutionize oncology pipelines and mark a new era for personalized medicine. With the recent approvals of Yescarta and Kymriah and the $11 billion acquisition of Kite, the race is on to lead the commercialization of safe, efficacious and accessible CAR-T therapy.
The fourth annual CAR-T congress USA is bringing together the leading pharmaceutical companies, the disruptive biotechs and pioneering academic institutions to assess emerging novel data and tackle the current challenges including antigen discovery, manufacturing scalability and efficacy.
Join discussions with Dr Christina Coughlin and Dr Leonard Lichtenfeld to determine how we avoid cheaper and more potent biologics hindering the progress of CAR-T, how we effectively edit T cells at scale, and how the industry is pushing for patient access to accelerate your CAR-T pipelines.
Discover first-hand the novel research being done by one of the leading ‘biotechs to watch’ Tmunity, as we explore the potential of CAR-T switches to control and manage CAR-T therapy effectively. Join Fate Therapeutics, TCR2 and Cellectis to determine how novel CAR-T constructs and gene editing technology are paving the way for the next generation CAR-Ts.
With two tracks for preclinical discovery and clinical development, refine your methods from optimizing T cell phenotypes and longevity to providing quality control for robust manufacturing. With sessions ran by Gilead and Legend Biotech on strengthening the business strategy for CAR-T and global regulation sessions ran by the EMA, this is your chance to be informed when commercialising your CAR-T therapy.
Be part of the movement that engineers a strategy to reprogram the cancer treatments we know today.
Take a look at our highlights video from 2018:
CAR-T 2018 IMAGE GALLERY
TESTIMONIALS
WHO WILL BE THERE
Network with industry experts from:
- Big pharma and biotech
- Cell Therapy Academics and clinicians
- Process standardisation - technology/services
- Logistics companies - cell storage/transport
- Service providers - CRO’s, Consultants, Government
Past attendees include:
The Agenda
Take a look at our agenda preview for the hot topics we'll be covering. Please fill in your details so we know who to send this too.
Check out the highlights from 2018:
Download Agenda
The Speakers
Kim Nguyen, PhD
Kim is a part of the Cell Therapy team at Precision Biosciences focused on the process development, analytics, and manufacturing of allogeneic CAR-T cell products. Before joining Precision Biosciences, she served as Principal Scientist and Senior Manager for Strategic Initiatives at Terumo BCT. Kim received her AB from Princeton University and her Ph.D. from Columbia University, both in Chemistry. She enjoys cooking Vietnamese food, reading, and adventures with her adorable Jack Russell terrier, Grover, aka Mr. Shambles.
Robert Tighe
Dan Shoemaker
Ali Mohamed
Paul Lammers
Professor David Miklos
Therese Solstad Saunders
Professor Saar Gill
Professor Sattva Neelapu
Peter Emtage
Dr. Emtage currently serves as Chief Scientific Officer at Cell Design Labs, Inc. (CDL). Prior to joining CDL, he was Vice President of Synthetic Immunology at Intrexon Corporation and was Vice President of Immune Mediated Therapy in the Oncology Innovative Medicines group at Medimmune. At Medimmune, Dr. Emtage designed and implemented a comprehensive immune therapy cancer strategy. He has over sixteen years of biologics development experience in the fields of oncology, autoimmunity, infectious diseases, and inflammation. Dr. Emtage holds a B.S. and M.S. in Molecular Biology and Genetics from the University of Guelph and received his Ph.D. in Molecular Virology, Immunology and Inflammation at McMaster University. At the beginning of his career, he also was a post-doctoral fellow at the National Institutes of Health and held roles at Aventis Pasteur and Harvard Medical School.
Dr. John McHutchinson
Dr. Christina Coughlin
Hans-Peter Gerber
Dr. Alexandre Juillerat
Dr. Leonard Lichtenfeld
Dr. Francesco Galimi
Dr. Avery Posey
Dr. Saul Priceman
Fred Koller, Ph.D.
Welf Ludwig
Dr. Qiong Wang
Dr. Matthew Spear
Dr. Kristen Hege
Rob Margolin
Dominic Clarke
Ryan Crisman, PhD
Dr Angeliki Grammenos
Angeliki has held positions in academia and biopharma, with a special focus in cell therapy.
Angeliki is a physicist by training and has a PhD in biophysics specialized in cell biology. She left her teaching position at the University of Liège in 2012, to join the international office of Doctors Without Borders where she assisted the Ethical review board as well as the Quality Assurance department of the movement.
In 2015, she joined Bone Therapeutics S.A, a biopharmaceutical company dedicated to the development of cell therapy products based on autologous and allogeneic adult stem cell technology to treat unmet medical needs in the field of bone disease where she led the RA Department.
In 2018, Angeliki joined Celyad, a biopharmaceutical company specialized in autologous and allogeneic cell therapy. Celyad’s core business lies in immune-oncology and the development of NK-receptor based CAR T therapies.
Dr. Leon Song
Dawn Driscoll
Madhusudan Peshwa
Stefano Baila
Stefano Baila received his PhD in 2007 based upon translational research and development of gene therapies for hemophilia at the Children’s Hospital of Philadelphia. Since that time he has been actively involved in the process development and manufacturing of advanced therapeutic medicinal products through business development and strategic marketing roles at Areta International, a CDMO, and by leading field implementation and commercialization activities for the cell processing unit of Terumo BCT. Stefano also worked as Industrialization Manager at Celyad where he led process development and automation efforts for CAR-T therapeutics. Now he serves as Director of Operation and Business Development for Anemocyte.
Headline Partner
Platinum Partners
Gold partners
Event Partners
Media Partners
PARTNER WITH US
Based on your objectives, we can create bespoke packages designed specifically for you. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding, and Networking.
Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected]
Venue
Hyatt Regency Boston Harbor, 101 Harborside Drive, Boston, MA 02128
This year's 4th Annual CAR-T Congress will be taking place in Hyatt Regency Boston Harbor, 101 Harborside Drive, Boston, MA 02128
Hyatt Regency Boston Harbor is an intimate and boutique-style Harborside hotel with breathtaking views of the beautiful city skyline. Guests will appreciate the proximity to Logan Airport and the hotel’s complimentary airport shuttle. Boston’s famed cultural and historical sites, recreational options, and neighborhoods are just minutes away and easily accessible through our many public transportation options available including the MBTA Train and Water Taxi.
Unfortunately, there are no rooms available at the Hyatt Regency, please contact the Embassy Suites Hotel near Logan Airport who have rooms available. The Embassy Suites Hotel is a 6-minute taxi from the Hyatt Regency or alternatively, there is a free shuttle bus between the hotels.
Accessibility:
We are committed to making our event accessible to everyone. If you are traveling for the event, Cloud of Goods provides mobility scooter rentals, wheelchair rentals, and other mobility solutions. They will deliver directly to you at the event, your hotel, the airport, or any other place of your choosing. Event attendees will receive a 20% discount when they use the code: RENTGEAR032
Conference Packages
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.
